Hemodynamic Monitoring Systems Market is expected to touch USD xx million by 2025


Posted November 5, 2019 by venkatapbi

The Global Hemodynamic Monitoring Systems Market was valued at US$ 268.3 Mn in 2018 and is expected to grow at a significant CAGR over six years forecast period 2019-2025
 
Hemodynamic Monitoring Systems Market Size and Growth Rate:

“The Global Hemodynamic Monitoring Systems Market was valued at US$ 268.3 Mn in 2018 and is expected to grow at a significant CAGR over six years forecast period 2019-2025 owing to upsurge in the number of critically ill elderly cases and growing mandate for home-based and non-invasive monitoring systems”

Hemodynamic Monitoring Systems Market Growth Drivers and Restraints:

The global hemodynamic monitoring systems market was valued at US$ 268.3 Mn in 2018 and growing at a CAGR of 4.1% over the forecast period owing to surge in the number of critically ill elderly cases, increase in the occurrence of cardiac disorders (According to WHO reports, in 2012, globally about 17.5 Mn deaths are recorded because of cardiovascular diseases) and diabetes, growing demand for home-based and non-invasive monitoring systems, technological advancements, owing to funding by private players and government bodies, and upsurge in the number of people suffering from hypertension are the major factors driving the growth of the market. However, rising incidence of adverse reactions related along with hemodynamic monitoring systems, stringent FDA regulations for the approval of new systems are the major restrains hinders the growth of the market.

Browse More Details of the report @ https://www.precisionbusinessinsights.com/market-reports/global-hemodynamic-monitoring-systems-market/

Hemodynamic monitoring systems segment accounted for higher revenue share

Based on product, global hemodynamic monitoring systems market is segmented into Hemodynamic Monitoring Systems and disposables. Hemodynamic monitoring systems segment accounted for the largest market share in 2018 and is expected to grow with highest CAGR over the forecast period owing to the incidence of a large patient populace undergoing diagnosis for vascular diseases, growing adoption of disposables among medical professionals due to their practical and technical benefits, and continuing advancements in catheters, sensors, probes, and guidewires. Additionally, the increasing incidence of risk factors for vascular diseases (such as obesity, hypertension, alcoholism, and diabetes) is also projected to support the growth of this market.
Asia Pacific holds leading position in Global Hemodynamic Monitoring Systems Market

PBI’s global hemodynamic monitoring systems market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, Asia Pacific is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to increasing occurrence of vascular disease, developing technological advancements, hurried growth in the economy and promising initiatives by the government. Latin America is anticipated to show significant growth owing to changing lifestyles and rising prevalence of cardiovascular disease. According to World Heart Federation, Latin America holds the high risk of abdominal obesity, high blood cholesterol, hypertension etc.
Recent Developments in the Global Hemodynamic Monitoring Systems Market

 In June 2017, LiDCO received 510k clearance from U.S.FDA FOR its new advanced hemodynamic monitoring platform LiDCOunity.
 In April 2017, Edwards Life sciences Corporation, received FDA clearance for HemoSphere advanced monitoring platform used to provide clarity on hemodynamics of the patient.
 In May 2015, Cheetah Medical received U.S.FDA clearance and CE-mark approval from Europe for it’s a non-invasive hemodynamic monitoring system Starling SV.

Key player’s profiles in the report are LiDCO Group plc (U.K.), PULSION Medical Systems SE (Germany), Deltex Medical Group Plc. (U.K.), Cheetah Medical Inc. (Israel), Hemo Sapiens Inc. (U.S.), Osypka Medical GmbH (Germany), ICU Medical, Inc. (U.S.), Tensys Medical, Inc. (U.S.). Edwards Life sciences Corporation (U.S.) and Schwarzer Cardiotek GmbH (Germany).

Ask For Sample of the report @ https://www.precisionbusinessinsights.com/request-sample?product_id=17041

Detailed Segmentation of Hemodynamic Monitoring Systems Market:

By Product
o Hemodynamic Monitoring Systems
o Disposables

By Type
o Non invasive
o Invasive
o Minimally invasive

By End User
o Hospitals
o Diagnostic centers
o Catheterization laboratories

Geography

o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Precision Business Insights
Country India
Categories Health
Tags hemodynamic monitoring systems market
Last Updated November 5, 2019